23 Jul, 2026
According to Straits Research the global bioactive materials market was valued at $3.08 billion in 2025 and is anticipated to grow from $3.56 billion in 2026 to $11.23 billion by 2034, registering a CAGR of 15.46% during the forecast period 2026–2034.Bioactive materials interact with biological systems, including cells, tissues, and organs. These synthetic or natural materials are predominantly employed in medical applications like tissue engineering, drug delivery, and regenerative medicine. They can also be used for drug delivery, where the substance is designed to release a drug or therapeutic agent gradually. This can be advantageous for targeted drug delivery, in which the drug is released directly into the affected tissue, thereby reducing adverse effects and increasing efficacy. As a result, bioactive materials are gaining widespread popularity worldwide, as they have many applications in the medical field and are a crucial tool for advancing the treatment of different diseases and conditions.
Growing Demand for Dental Care and Root Canal Treatment Drives the Global Market
In dental care applications, bioactive biomaterials are increasingly used to manage tissue loss caused by congenital or acquired diseases such as dental caries, periodontitis, and bone defects. These materials will serve multiple purposes, such as inhibiting bacterial biofilm formation, remineralizing mineral loss in dental hard tissues such as dentin and enamel, and regenerating diseased pulp bone soft tissues.
Portland cement or mineral trioxide aggregate (MTA) is a bioactive material utilized in root canal therapy to preserve the vitality of pulp and periodontal tissue during pulp capping and perforation repair procedures. Caries of permanent teeth are estimated to affect 2 billion people worldwide, while caries of primary teeth affect 520 million children. As a result, the dental care industry will likely experience increased demand for bioactive materials.
Rising Healthcare Market in Emerging Economies Creates Tremendous Opportunities
The market for bioactive materials in emerging economies is expected to develop substantially throughout the forecast period. This is largely attributable to the increasing patient population, the increasing adoption of implantable devices, the increasing awareness of cardiovascular diseases, the increasing disposable income, the improving healthcare infrastructure, and the less stringent regulatory guidelines (compared to developed nations) in these nations.
The economies of Brazil, Russia, India, China, and South Africa (BRICS) have some of the highest growth rates in the world. As per the World Economic Forum, these emerging economies contributed one-third of global healthcare expenditures in 2020. Some of the main factors anticipated to accelerate the demand for advanced healthcare services and new medical devices in the healthcare systems of these nations are the rising demand for surgical procedures, the surging geriatric population, and the rising incidence of target diseases. This will provide growth opportunities for bioactive material market participants in the coming years.
North America is the most significant global bioactive materials market shareholder and is estimated to exhibit a CAGR of 15.85% during the forecast period. Due to the United States' highly developed healthcare industry and ongoing investments in the medical technology industry, North America is estimated to dominate the global market. The healthcare industry in the United States is among the most advanced in the region. As per the Centers for Medicare and Medicaid Services, between 2021 and 2028, national healthcare expenditures are projected to increase by an average of more than 5.5%, reaching approximately USD 6.192 trillion by 2028. Moreover, the increasing number of forest fires in the US is a leading cause of burns and even trauma injuries caused by accidents in the region where tissue, bone, and ligament regeneration uses bioactive materials, boosting the market.
In 2022, the total health expenditures in Canada amounted to USD 245.72 billion, predicted to increase to USD 264.5 billion by the year's conclusion. Surgical procedures require sophisticated medical equipment and components, such as bioactive substances. This, along with the use of these materials in the pharmaceutical industry, is expected to propel the North American bioactive materials market in the coming years.
Europe is estimated to exhibit a CAGR of 13.72% over the forecast period. Europe is the second-largest market in this industry due to the region's extremely rapid geriatric population growth, increases in life expectancy, and rising prevalence of musculoskeletal diseases. According to the National Health Service (NHS), approximately 10 million people in the United Kingdom have arthritis, 8.5 million of whom have osteoarthritis. In addition, based on the results of the first medium-term population projection by the Federal Statistical Office (Destatis), the number of people aged 67 or older is expected to rise by 22% between 2020 - 2035, from 16 million to 20 million. The regional market for bioactive materials is also anticipated to benefit from the surging demand for bioactive materials in orthopedics, dentistry, and wound care. According to Statista's Consumer Market Outlook, France is one of Europe's largest oral care markets, with revenues of approximately USD 1.25 billion in 2020, increasing demand for bioactive materials in dental care applications.
sales@straitsresearch.com